2 different filers disclosed IQV within 90 days. Disclosed 44 days after the transaction; reported as an official range, not an exact amount.
Traded Oct 29, 2025 · Filed Oct 31, 2025
A board member of IQVIA sold $174K of IQVIA shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$174,064
Shares × reported transaction price
1 day after results of Oct 28, 2025, 99 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $217.83 on Oct 29, 2025, within 2% of its 52-week high, after a 17% rise over the previous 30 trading days
52-week range $137.00 (May 23, 2025) to $221.25 (Nov 6, 2024), 96% of the way up, from 250 adjusted closes. 30 trading days earlier: $186.69 on Sep 17, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.4% | -0.3% | -0.1% |
| 30 days | +6.3% | +0.1% | +6.2% |
| 90 days | +8.1% | +1.8% | +6.3% |
| 180 days | -24.8% | +5.1% | -29.8% |
Past results only. Not a forecast.
2 different filers disclosed IQV within 90 days. Disclosed 44 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.